124 related articles for article (PubMed ID: 461171)
1. [Surveillance of women taking oral contraceptives by determination of antithrombin III].
Benoit MO; Raichvarg D; Caillens H; Neau C
Nouv Presse Med; 1979 Feb; 8(7):528-9. PubMed ID: 461171
[TBL] [Abstract][Full Text] [Related]
2. [Oral contraceptive agents and antithrombin III].
Kamenov V; Nalbanski B
Akush Ginekol (Sofiia); 1990; 29(1):60-3. PubMed ID: 1695492
[TBL] [Abstract][Full Text] [Related]
3. The effect of levenogesterol (Norplant) contraception on coagulation as measured by antithrombin-III levels.
Pryor JA; Cooper KR; Bass JD; Hampton HL; Rock WA; Morrison JC
J Miss State Med Assoc; 1996 Oct; 37(10):777-9. PubMed ID: 8908950
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptives and deep venous thrombosis with pulmonary embolism.
Bouché RT; Medawar SJ; Dockery GL
J Foot Surg; 1982; 21(4):297-301. PubMed ID: 7186920
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
Jespersen J
Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
[TBL] [Abstract][Full Text] [Related]
6. Increased heparin cofactor II levels in women taking oral contraceptives.
Toulon P; Bardin JM; Blumenfeld N
Thromb Haemost; 1990 Nov; 64(3):365-8. PubMed ID: 2096488
[TBL] [Abstract][Full Text] [Related]
7. Study of the activity of antithrombin-III in latent cholestasis. (A clinico-pharmacological study of the relationship between antithrombin-III activity and steroid cholestasis).
Horváth T; Nagy I; Gógl A
Acta Med Acad Sci Hung; 1978; 35(2):105-13. PubMed ID: 742337
[TBL] [Abstract][Full Text] [Related]
8. [Antithrombin 3 changes in women using oral contraceptives].
Conard J; Salomon Y; Samama M
Pathol Biol (Paris); 1974 Jan; 22(1):77-80. PubMed ID: 4592416
[TBL] [Abstract][Full Text] [Related]
9. The determination of antithrombin III. Comparison of six methods. Effect of oral contraceptive therapy.
Bounameaux H; Duckert F; Walter M; Bounameaux Y
Thromb Haemost; 1978 Jun; 39(3):607-15. PubMed ID: 705689
[TBL] [Abstract][Full Text] [Related]
10. Oral contraceptives and blood coagulation.
Bonnar J; Sabra AM
J Reprod Med; 1986 Jun; 31(6 Suppl):551-6. PubMed ID: 2941571
[TBL] [Abstract][Full Text] [Related]
11. Antithrombin III deficiency, deep venous thrombosis, and oral contraceptive use.
Werner MJ
J Adolesc Health; 1995 Sep; 17(3):189-92. PubMed ID: 8519788
[TBL] [Abstract][Full Text] [Related]
12. Balance of coagulation activity with fibrinolysis during use of oral contraceptives in women with insulin-dependent diabetes mellitus.
Petersen KR; Skouby SO; Jespersen J
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():105-11. PubMed ID: 8574252
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the prethrombotic state in pregnancy and in women using oral contraceptives.
Levine AB; Teppa J; McGough B; Cowchock FS
Contraception; 1996 May; 53(5):255-7. PubMed ID: 8724613
[TBL] [Abstract][Full Text] [Related]
14. Activation of coagulation in smoking and non-smoking women using a third-generation oral contraceptive containing desogestrel.
Fruzzetti F; De Negri F; Morale M; Ricci C; Ferrini L; Bersi C; Genazzani AR; Carmassi F
Eur J Contracept Reprod Health Care; 1999 Sep; 4(3):113-8. PubMed ID: 10574636
[TBL] [Abstract][Full Text] [Related]
15. Blood viscosity and thrombosis: clinical considerations.
Smith BD; La Celle PL
Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612
[TBL] [Abstract][Full Text] [Related]
16. [Oral contraceptives and antithrombin III].
Stormorken H
Tidsskr Nor Laegeforen; 1985 Nov; 105(32):2333. PubMed ID: 4082148
[No Abstract] [Full Text] [Related]
17. [The physiological inhibitors of blood coagulation. 1. Antithrombin III (AT III)].
Kase F; Pospísil J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(3):337-49. PubMed ID: 6194066
[TBL] [Abstract][Full Text] [Related]
18. [Oral contraception and the vascular risk].
Garnier LF; Gruel Y
Servir; 1989; 37(6):322-6. PubMed ID: 2517520
[TBL] [Abstract][Full Text] [Related]
19. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
20. [Should the use of oral contraceptives be stopped by the age of 40?].
Halttunen M
Duodecim; 2002; 118(16):1629-30. PubMed ID: 12271939
[No Abstract] [Full Text] [Related]
[Next] [New Search]
